Impact of 5‐Aminosalicylic acid discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study
Journal of Pediatric Gastroenterology and Nutrition · 2026-07 · 83 (1) · 96-107
DOI: 10.1002/jpn3.70415 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 26.03.2026. Verfasst von Giulia D'Arcangelo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Hepatology and Cystic Fibrosis Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Mesalamine, Colitis, Ulcerative, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
5‐Aminosalicylic acid (5‐ASA) is recommended as a first‐line medication in mild to moderate ulcerative colitis (UC), but indications regarding its use in children with moderate to severe disease treated with biologics are lacking. We aimed to evaluate the impact of discontinuing 5‐ASA in children with UC treated with anti‐tumor necrosis factor (anti‐TNF).
Methods
Retrospective, multicenter, case–control study of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition inflammatory bowel disease (IBD) study group. Children with UC starting anti‐TNF therapy between January 2018 and January 2023 and with a minimum follow of 6 months were included. Those who discontinued 5‐ASA (cases) were compared to those who continued mesalamine (controls). A Propensity Score analysis was used to match 1:2 with patients by baseline clinical and demographic characteristics. Every 6 months, during a 2‐year follow‐up, data on disease flares, IBD‐related hospitalization, surgery, need for step‐up treatment and acute severe colitis were recorded.
Results
Data from 298 children were collected (92 [31%] cases and 206 [69%] controls) and 227 were included in the final analysis after matching (85 [37.5%] cases and 142 [62.5%] controls]. Children who discontinued 5‐ASA were at higher risk of courses of steroids (Log‐Rank p = 0.003) and hospitalization ( p = 0.08). At the multivariate Cox regression analysis, 5‐ASA discontinuation was identified as an independent predictor of courses of steroids ( p = 0.003) and hospitalization ( p = 0.08).
Conclusions
5‐ASA discontinuation might negatively impact the clinical course of children with UC treated with anti‐TNF. Considering the good safety profile of the drug, continuing mesalamine can be suggested as a prudent approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology, Hepatology and Cystic Fibrosis Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano, Milan, Italy.
- Gastroenterology and Nutrition Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
- Department of NEUROFARBA, Meyer Children's Hospital, University of Florence, Florence, Italy.
- Paediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.
- Paediatric Gastroenterology, Ospedale Paediatrico Microcitemico A. Cao, ARNAS Brotzu, Cagliari, Italy.
- Department of Human Pathology in Adulthood and Childhood "G. Barresi", Paediatric Gastroenterology Unit, University of Messina, Messina, Italy.
ORCID-Profile: Marina Aloi
Förderung
- None
Zitieren
APA
D'Arcangelo, G., Scarallo, L., Mancuso, G., Corpino, M., Romano, C., Norsa, L., Arrigo, S., Bramuzzo, M., Fioretti, M. T., Zuin, G., Illiceto, M. T., Lionetti, P., & Aloi, M. (2026). Impact of 5‐Aminosalicylic acid discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study. Journal of Pediatric Gastroenterology and Nutrition, 83(1), 96-107. https://doi.org/10.1002/jpn3.70415
Vancouver
D'Arcangelo G, Scarallo L, Mancuso G, Corpino M, Romano C, Norsa L, et al. Impact of 5‐Aminosalicylic acid discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study. Journal of Pediatric Gastroenterology and Nutrition. 2026;83(1):96-107. doi:10.1002/jpn3.70415
BibTeX
@article{DArcangelo2026,
author = {D'Arcangelo, Giulia and Scarallo, Luca and Mancuso, Giulia and Corpino, Mara and Romano, Claudio and Norsa, Lorenzo and Arrigo, Serena and Bramuzzo, Matteo and Fioretti, Maria Teresa and Zuin, Giovanna and Illiceto, Maria Teresa and Lionetti, Paolo and Aloi, Marina},
title = {Impact of 5‐Aminosalicylic acid discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
volume = {83},
number = {1},
pages = {96--107},
doi = {10.1002/jpn3.70415}
}
EUVIMED